Effects of an anticoagulant and a lipid‐lowering agent on the prevention of steroid‐induced osteonecrosis in rabbits
Authors:
- 26 May 2010
- journal article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 91 (3) , 235-243
Abstract
Summary: This study was designed to evaluate the effects of the combined treatment with an anti‐coagulant (enoxaparin) agent and a lipid‐lowering agent (lovastatin) on prevention or decrease in the occurrence of steroid‐induced osteonecrosis in rabbits. A total of 112 rabbits, which were injected intramuscularly with 20 mg/kg of methylprednisolone acetate were divided into four groups and treated as follows: one group received enoxaparin combined with lovastatin (EL; n = 30), another received enoxaparin alone (EA; n = 28), another received lovastatin alone (LA; n = 28) and the last received no treatment (non‐prophylactic; NP, n = 26). Haematological examination for serum lipid levels and prothrombin time was carried out and both femora and humeri were examined histopathologically for the presence of osteonecrosis (ON) before injection and at 2, 4, 8 and 12 weeks after the injection. The incidence of ON in the EL group (15%) was significantly lower than that observed in the NP group (68%). The incidence in the EA and LA groups was also significantly lower than that in the NP group (31%, 35%vs. 68%). The fat cell sizes of the bone marrow in both EL (46.49 ± 1.27 μm) and LA (50.8 ± 2.31 μm) groups were lower than in the NP group (59.89 ± 6.33 μm). The prothrombin time was prolonged and plasma lipid levels were reduced in the EL group during the study. Combination treatment with an anti‐coagulant agent and a lipid‐lowering agent can reduce the incidence of steroid‐induced ON in rabbits. Future evaluation in clinical practice is necessary.Keywords
This publication has 38 references indexed in Scilit:
- Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid‐induced osteonecrosis in a rabbit modelJournal of Orthopaedic Research, 2007
- Type II Collagen Gene Variants and Inherited Osteonecrosis of the Femoral HeadNew England Journal of Medicine, 2005
- Combined effects of an anticoagulant and a lipid‐lowering agent on the prevention of steroid‐induced osteonecrosis in rabbitsArthritis & Rheumatism, 2004
- ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantationPharmacogenetics, 2003
- Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell culturesBone, 2003
- The Pathogenesis and Prevention of Steroid Induced OsteonecrosisClinical Orthopaedics and Related Research, 2000
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999
- Effects of pulse methylprednisolone on bone and marrow tissues. Corticosteroid‐induced osteonecrosis in rabbitsArthritis & Rheumatism, 1997
- Lovastatin Prevents Steroid Induced Adipogenesis and OsteonecrosisClinical Orthopaedics and Related Research, 1997
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987